Filing Flows › Inhibrx Biosciences (INBX) › How it makes money
How Inhibrx Biosciences (INBX) makes money
Inhibrx Biosciences (INBX) made $1.3M of revenue in the second quarter 2025 (Q2 2025), up 13-fold from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2025 | % of revenue |
|---|---|---|
| Revenue | $1.3M | 100.0% |
| Income tax | $2K | 0.2% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2025 | $1.3M | 13× |
| Q4 2024 | $100K | -94% |
From Inhibrx Biosciences' 10-Q filed Aug 13, 2025 (on EDGAR).
Questions
How does Inhibrx Biosciences make money?
Inhibrx Biosciences (INBX) made $1.3M of revenue in the second quarter 2025 (Q2 2025), up 13-fold from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.